Forschungspartner
In der Helmholtz-Wirkstoffforschung haben sich die Helmholtz-Zentren des Forschungsbereichs Gesundheit sowie das Leibniz-Institut für Molekulare Pharmakologie als externer Partner zusammengeschlossen.
News
- 13. Januar 2020
Significant steps taken in the development of potential new cancer treatments
Together with the European Lead Factory (ELF), scientists from the German Cancer Research Center (DKFZ) have successfully discovered potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases. Published in ChemMedChem, the findings mark a significant step in the development of potential new cancer treatments.
weitere Informationen - 10. Januar 2020
POSTPONED! HDDC 2020: 3rd Helmholtz Drug Discovery Conference
weitere Informationen